The incidence of colon cancer is rising among people under the age of 50, so researchers at the Regenstrief Institute, the VA and the IU School of Medicine are developing and validating a model to predict risk for colon cancer in those under 50 with no family history of the disease.
Cancer patients with advanced disease fared better when they received genomic-guided therapy, according to a study by Indiana University School of Medicine researchers.
Thursday, September 01, 2016
Friday, September 09, 2016
Thursday, September 15, 2016
Friday, September 16, 2016